Nutrition Business Journal

Ingredients That Differentiate Joint Care Products Should Thrive as Glucosamine Flattens

Despite survey data showing that safety concerns prompted many arthritis sufferers to switch from drugs to supplements last fall, some manufacturers of joint-care supplements said the COX-2 inhibitor recalls and warnings were insignificant to the category. “We’re seeing an increase in sales, but I don’t believe it has anything to do with the prescription drug issue,” said Harvey Kamil, president & chief financial officer of NBTY, which markets Osteo Bi-Flex and o

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.